• Drug and Health Product Submissions Under Review (SUR): New drug submissions completed
• Draft guidance on management of rolling reviews for drug submissions: Performance targets …
• Notice: New regulations strengthening the post-market surveillance and risk management of medical …
• Notice of clarification to drug manufacturers and sponsors - Risk Management Plans …
• Notice of clarification to drug manufacturers and sponsors: Canadian-specific considerations in risk …